Patents by Inventor Andrew B. Bush

Andrew B. Bush has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGF modulation of in vivo antibody production and humoral immunity
    Patent number: 9884116
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: February 6, 2018
    Inventor: Andrew B. Bush
  • FGF MODULATION OF IN VIVO ANTIBODY PRODUCTION AND HUMORAL IMMUNITY
    Publication number: 20160235841
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Application
    Filed: May 2, 2016
    Publication date: August 18, 2016
    Inventor: Andrew B. Bush
  • FGF modulation of in vivo antibody production and humoral immunity
    Patent number: 9359433
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: June 7, 2016
    Inventor: Andrew B. Bush
  • FGF MODULATION OF IN VIVO ANTIBODY PRODUCTION AND HUMORAL IMMUNITY
    Publication number: 20160060334
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Application
    Filed: November 11, 2015
    Publication date: March 3, 2016
    Inventor: Andrew B. Bush
  • FGF modulation of in vivo antibody production and humoral immunity
    Patent number: 9226960
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: January 5, 2016
    Inventor: Andrew B. Bush
  • FGF modulation of in vivo antibody production and humoral immunity
    Patent number: 9107908
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: August 18, 2015
    Inventor: Andrew B. Bush
  • FGF MODULATION OF IN VIVO ANTIBODY PRODUCTION AND HUMORAL IMMUNITY
    Publication number: 20130236474
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Application
    Filed: May 3, 2013
    Publication date: September 12, 2013
    Inventor: Andrew B. Bush
  • FGF MODULATION OF IN VIVO ANTIBODY PRODUCTION AND HUMORAL IMMUNITY
    Publication number: 20130236483
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Application
    Filed: May 6, 2013
    Publication date: September 12, 2013
    Inventor: Andrew B. Bush
  • FGF modulation of in vivo antibody production and humoral immunity
    Patent number: 8435525
    Abstract: The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
    Type: Grant
    Filed: November 7, 2010
    Date of Patent: May 7, 2013
    Inventor: Andrew B. Bush